KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Other Operating Expenses (2016 - 2025)

Vertex Pharmaceuticals has reported Other Operating Expenses over the past 17 years, most recently at $523.4 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $523.4 million for Q4 2025, up 2.69% from a year ago — trailing twelve months through Dec 2025 was $2.2 billion (down 64.84% YoY), and the annual figure for FY2025 was $2.2 billion, down 64.84%.
  • Other Operating Expenses for Q4 2025 was $523.4 million at Vertex Pharmaceuticals, up from $467.4 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for VRTX hit a ceiling of $4.8 billion in Q2 2024 and a floor of $188.4 million in Q1 2021.
  • Median Other Operating Expenses over the past 5 years was $409.2 million (2024), compared with a mean of $660.6 million.
  • Biggest five-year swings in Other Operating Expenses: surged 1052.09% in 2024 and later crashed 91.48% in 2025.
  • Vertex Pharmaceuticals' Other Operating Expenses stood at $371.9 million in 2021, then dropped by 17.26% to $307.7 million in 2022, then rose by 9.03% to $335.5 million in 2023, then skyrocketed by 51.92% to $509.7 million in 2024, then rose by 2.69% to $523.4 million in 2025.
  • The last three reported values for Other Operating Expenses were $523.4 million (Q4 2025), $467.4 million (Q3 2025), and $410.6 million (Q2 2025) per Business Quant data.